PHB1 and diffuse large B-cell lymphoma: Our findings on DLBCL cell lines and DLBCL xenograft murine model show PHB involvement in ERK-MNK-eIF4E and Akt pathways and strongly suggest that targeting PHBs using flavaglines may be a potential therapeutic strategy in DLBCL.